OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements ...

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...

A special last wish was granted for a Calaveras County hospice patient facing a daunting diagnosis. Janet McAnnally, 79, was ...

Lung cancer is the leading cause of cancer deaths in New Hampshire and across the U.S., but the American Lung Association’s 2024 State of Lung Cancer report indicates ...

But a lot of work remains to get eligible people screened for lung cancer and expand affordable access to the targeted ...

“It’s the first clinically validated test on the market,” Zaidi told Pittsburgh Magazine. “And one of the most highly ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...

bioAffinity Technologies, Inc. is a biotechnology company dedicated to providing noninvasive diagnostic tests for early-stage lung cancer and other lung diseases ... substantial progress in expanding ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...